Federal grant · project grant (b)
Novel, Targeted Method for Bacteriophage Purification - Project Summary the Fields of Gene Therapy and Bacteriophage Therapy Are Rapidly Expanding and Show Promising Potential for Treating Genetic Disorders and Antibiotic Resistant Bacterial Infections, Respectively. to Meet These Needs, Improved High Throughput and High Affinity Viral Purification Methods Will Be Required. Current High Throughput Viral Purification Methods Mainly Consist of Resin-based Chromatography Coupled With Multiple Filtration Steps. Chromatography-based Methods Often Lack Specificity for the Particular Virus Target. for Example, the Commonly Used Ion Exchange Resins Are Not Able to Separate Contaminants Sharing Similar Surface Net Charges to the Virus Particles. Selection of Mixed Virus Varieties Such as Viruses of Different Serotypes Cannot Be Achieved With Chromatography Methods. Affinity-based Resin Chromatography Products Targeting Viral Vectors Exist But Are Expensive or Not Suitable for Large-scale Purification. Additionally, They Involve Coupling a Binding Entity to Resin, Which Presents Several Disadvantages, Including Leaching of the Affinity Ligand From the Chromatography Support or the Ligand Co-eluting With the Virus Particles. Thus, Improved Methods for Simple, Rapid, and Scalable Purification of Viral Vectors Are Needed to Serve Both the Small-scale Research Community and Large-scale Industrial Production. Bondwell Technologies Proposes to Develop a Novel Purification System for Large Biomolecules, Such as Viral Vectors. the Unique Qualities of Our Functionalized Biomaterial Provide Tremendous Versatility and Addresses the Current Limitations of Small- and Large-scale Viral Purification. During This Proposed Phase I Effort, We Will First Functionalize Our Biomaterials With an Entity Capable of Specifically Recognizing a Viral Target. We Will Then Test the Biomaterial for Their Ability to Bind the Viral Target. Finally, We Will Prepare Our Biomaterial to Be Used as a Membrane and Test Its Ability to Bind a Viral Target With Different Complexities of Starting Material (e.g., With Cellular Debris Present).
Committed
$275,384
Loading…
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then unspent ceiling.